ONCOLOGY
October 14, 2022
Ventana PD-L1 (SP142) Assay
This test evaluates programmed death-ligand 1 expression in triple-negative breast cancer by analyzing a biopsy sample of the cancerous tissue.
October 14, 2022
Review of Selected NMEs 2022
August 16, 2022
Understanding Sunburn Prevention and Management Strategies
February 11, 2022
Breast Cancer and Cardiovascular Disease Risk
January 14, 2022
Pharmacist Involvement in Antibody-Drug Conjugate Therapy
December 17, 2021
Incidence, Survival, and Mortality Rates for Colorectal Cancer
October 19, 2021
First CDK4/6 Inhibitor for HR+ HER2Ð High-Risk BC
October 19, 2021
Research Reveals Two Forms of Metastatic Prostate Cancer
October 15, 2021
Review of Selected NMEs 2021
October 5, 2021
Take Quiz: Ovarian Cancer
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2023 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.